<DOC>
	<DOCNO>NCT00183950</DOCNO>
	<brief_summary>This study patient non-hodgkin 's lymphoma chronic lymphocytic leukemia , fail shrink return previous treatment chemotherapy . The purpose study find whether patient type cancer tumor shrink treatment drug call Noscapine . The second purpose see side effect drug . This drug use over-the-counter cough suppressor Europe Japan , also show effective cancer .</brief_summary>
	<brief_title>Study Noscapine Patients With Low Grade Non Hodgkin 's Lymphoma Chronic Lymphocytic Leukemia Refractory Chemotherapy</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Lymphoma , Non-Hodgkin</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Leukemia , Lymphocytic , Chronic , B-Cell</mesh_term>
	<mesh_term>Noscapine</mesh_term>
	<criteria>Patients low grade NHL ( follicular lymphoma , small cell lymphocytic lymphoma , marginal cell lymphoma , monocytoid Bcell lymphoma , MALT lymphoma , plasmacytoid lymphocytic lymphoma ) chronic lymphocytic leukemia demonstrate chemotherapy resistance ( achieve CR , CRu , PR ) relapse time follow response ( CR , CRu , PR ) least one therapy regimen , include chemotherapy , Rituximab , high dose chemotherapy stem cell rescue . Karnofsky performance status 60 % great . Creatinine le equal 2.0 mg/dl , bilirubin le equal 2.0 mg/dl , SGPT/SGOT le equal 4 x upper normal range Patients unconfirmed complete response ( CRu ) last treatment currently remain CRu . Pregnant lactate woman . Diseasespecific treatment le 1 month prior start study . CNS disease . HIVpositive patient . Other cancer , except basal cell squamous cell cancer skin carcinoma insitu cervix .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
</DOC>